Brenntag and Evonik REXIM: exclusive GMP amino acids distribution across most of Europe
- Effective July 1, 2026, Brenntag assumes full market development and distribution responsibility for REXIM® GMP amino acids across most of Europe.
- Geographic coverage includes DACH, UK, France, Benelux, Scandinavia, CEE, Israel and Turkey; Italy, Ukraine, Middle East and Africa are excluded.
- Products are highly purified natural and non‑natural amino acids and derivatives for medical nutrition, pharmaceutical APIs and excipients, and cell-culture media.
- Evonik REXIM supplies relevant production from domestic European sources using fermentation, bioconversion and synthetic manufacturing; partnership aims to enhance local service and supply security.
Deal scope and timing
From July 1, 2026, Brenntag will assume exclusive responsibility for market development and distribution of Evonik REXIM® GMP-grade amino acids across most of Europe, covering the DACH region, UK, France, Benelux, Scandinavia, CEE, Israel, Turkey and more, while Italy, Ukraine, the Middle East and Africa are excluded.
Product and applications
REXIM® provides highly purified natural and non‑natural amino acids and derivatives suitable for regulated applications. The portfolio is positioned for medical nutrition, pharmaceutical APIs and excipients, and as consistent nutrients for cell-culture media in biopharma.
Supply and manufacturing
Evonik REXIM combines fermentation, bioconversion and synthetic-based manufacturing and offers relevant parts of production from domestic European supplies. The collaboration is intended to expand Evonik REXIM’s presence in key markets and provide customers with enhanced local service, technical support and longer-term supply security.
Leadership statements
Brenntag framed the partnership as aligning Evonik’s GMP amino acids with its regional market presence, technical capabilities and regulatory know‑how to support pharmaceutical and biopharmaceutical manufacturers. Evonik highlighted Brenntag’s regional footprint and life‑science experience as critical to strengthening market reach and customer access to high-quality GMP amino acids.
Source: Brenntag
